1. Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
2. Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada5Hereditary Cancer Program, BC Cancer Agency, Vancouver, British Columbia, Canada
3. Expression Regulation in Cancer Group, IPATIMUP–Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal
4. Hereditary Cancer Program, BC Cancer Agency, Vancouver, British Columbia, Canada
5. Division of Anatomical Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
6. Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada
7. The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada9Rosalind and Morris Goodman Cancer Research Centre, Montreal, Quebec, Canada
8. Human Reproduction Service, University Hospitals of Coimbra, Coimbra, Portugal11Faculty of Medicine, University of Coimbra, Coimbra, Portugal
9. Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Lisbon Portugal
10. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada7Department of Molecular Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada
11. Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
12. Frauenshuh Cancer Center, Park Nicollet Clinic, St Louis Park, Minnesota
13. Cancer Research UK Cambridge Institute, Cambridge, England
14. Provincial Medical Genetics Program, St John’s, Newfoundland, Canada
15. Department of Health Science Research, Mayo Clinic, Scottsdale, Arizona
16. Cancer Care Program, Dr. H. Bliss Murphy Cancer Centre Eastern Health, St John’s, Newfoundland, Canada
17. Institute of Pathology, Technische Universität München, München, Germany
18. Creighton’s Hereditary Cancer Center, Omaha, Nebraska
19. Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
20. Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada22Samuel Lunenfeld Research Institute, Mount Sinai Hospital Toronto, Ontario, Canada
21. Department of Experimental Oncology, European Institute of Oncology, Milano, Italy24Department of Medical Surgical Sciences and Neurosciences, Section of General Surgery and Surgical Oncology, University of Siena, Siena, Italy
22. Department of Medical Surgical Sciences and Neurosciences, Section of General Surgery and Surgical Oncology, University of Siena, Siena, Italy25Istituto Toscano Tumori (ITT), University Hospital of Siena, Siena, Italy
23. Expression Regulation in Cancer Group, IPATIMUP–Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal26Faculty of Medicine, University of Porto, Porto, Portugal
24. Department of Oncology, University of Cambridge, Strangeway’s Research Laboratory, Wort’s Causeway, Cambridge, England28Department of Public Health and Primary Care, University of Cambridge, Strangeway’s Research Laboratory, Wort’s Causeway, Cambridge, En
25. Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada7Department of Molecular